A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA

BACKGROUND: Methylated SDC2 has been proved as a diagnostic marker for human colorectal cancer (CRC), noninvasive stool DNA-based methylation testing also emerges as a novel approach for detecting CRC. The aim of this study was to evaluate the clinical performance of stool DNA-based SDC2 methylation...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Liang, Qin, Geng, Gai, Fei, Jiang, Yongwei, Huang, Zhan, Yang, Hui, Yao, Shukun, Du, Shiyu, Cao, Yongtong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014784/
https://www.ncbi.nlm.nih.gov/pubmed/35436855
http://dx.doi.org/10.1186/s12876-022-02264-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014784/
https://www.ncbi.nlm.nih.gov/pubmed/35436855
http://dx.doi.org/10.1186/s12876-022-02264-3

Ejemplares similares